The 12 closest competitors and alternatives to CAMP4 Therapeutics Corporation among biotech companies — ranked by similarity to what CAMP4 Therapeutics Corporation actually does, not by market-cap band.
Subscribe to see CAMP4 Therapeutics Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
CAMP4 Therapeutics Corporation is a biotech company headquartered in Cambridge, United States. It is publicly listed (CAMP) with a market capitalisation of $236.6M. Xcout tracks 36 named people at CAMP4 Therapeutics Corporation, including Joshua Mandel-Brehm (Chief Executive Officer, President & Director).
30 more named people on record for CAMP4 Therapeutics Corporation, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $45M | 2 named |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to CAMP4 Therapeutics Corporation by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Biotechnology
Tasca Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, leveraging a unique platform to exploit lipid-binding pockets on proteins.
Similar biotech company
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Similar biotech company
Basecamp Bio Inc. is a California-based drug discovery and development company founded in 2021. The company utilizes a structure-based drug discovery engine to develop new drugs, cell and gene therapies, regenerative medicine, and immunotherapies.
Biotechnology
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Similar biotech company
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Biotechnology
Arena BioWorks is a biotechnology research organization located in Cambridge, Massachusetts, focused on translating human biology and disease mechanisms into breakthrough medicines.
Similar biotech company
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Biotechnology
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Life Sciences
GreenLight Biosciences, Inc. is a biotechnology company headquartered in Medford, Massachusetts, that develops sustainable platform solutions for various markets.
Similar biotech company
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Similar biotech company
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CAMP4 Therapeutics Corporationand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →